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Introduction
Depression is the leading cause of disability worldwide and also a major contributor to the overall global burden of disease. 1 The World Health Organization predicts that by 2020 depression will become the second leading cause of disease worldwide. 2 Unless properly treated, depression can cause significant problems in a person's life. In addition, depression is associated with suicidal ideation. 3 A review showed that resilience may prevent depressive symptoms, or at least reduce their impact. 4 Thus, resilience is an important outcome to be assessed in subjects with depression.
Resilience is a complex multidimensional construct and few studies have assessed the factors involved in this phenomenon. It is known that stressful life events are associated with posttraumatic stress disorder, 5 depression, and other psychiatric disorders. 6 However, subjects can be exposed to stressful life events and not develop psychiatric disorders, a mechanism known as resilience. Thus, resilience is the ability to adapt successfully in the face of stress and adversity, maintaining normal psychological and physical functioning. 7 One way to measure resilience is using scales. In Brazil, to the best of our knowledge, there is only one scale available to assess resilience, namely, the 
Methods
This was a follow-up clinical study nested in a doubleblind randomized clinical trial of two brief cognitive therapies (seven sessions): cognitive-behavioral therapy (CBT) 16 and narrative cognitive therapy (NCT).
17
The participants were drug-free young adults recruited Sixty-eight patients completed the study and were assessed post-intervention, and 61 patients were assessed at six-month follow-up. Table 1 
Results
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Discussion
This study aimed to assess the impact of resilience on severity of depressive and anxious symptoms after brief cognitive psychotherapies for depression.
The results showed that patients with higher baseline resilience scores showed less severe symptoms at postintervention and at six-month follow-up. In addition, the patients improved resilience scores at postintervention, and the improvement was maintained at six-month follow-up.
In this study, patients with higher baseline resilience scores showed less severe depressive and anxious symptoms at post-intervention. We found no studies that evaluated the effects of resilience on the improvement of depressive and anxious symptoms after psychotherapeutic interventions. However, a recent study found that higher levels of resilience are associated with higher levels of quality of life in subjects with bipolar disorder, schizophrenia, and heathy controls. 23 In addition, another study with patients with chronic obstructive pulmonary disease showed that resilience contributed significantly to reduce the levels of anxiety, depression, and stress. Likewise, it has also been shown to reduce disease-specific pulmonary impairment after drug intervention. 24 In this respect, the researchers emphasize that resilience may have an important role in the treatment of these disorders. 25, 26 We found that patients with higher baseline resilience scores showed less severe symptoms also at six-month follow-up. Some authors suggest that resilience is a protective factor that may help prevent relapse, since it is generally thought of as an adaptation in the face of adversity, trauma, tragedy, threats, or stress. 15, 27 In this sense, studies about resilience in a therapeutic context are important to reinforce the interaction of resilience with improvement of psychological well-being.
The results obtained for resilience were different at baseline vs. at post-intervention, i.e., less resilient patients showed higher resilience scores after treatment, demonstrating the possible effect of psychotherapy on resilience. Similarly, a study with depressed and anxious adolescents showed higher resilience scores as well as improvement of symptoms at post-treatment. 15 Another study examined the use of CBT to enhance resilience among adolescents whose parents were alcohol-dependent. The participants were submitted to 10 brief psychotherapy sessions.
Resilience scores increased significantly after the intervention. 28 These data together reinforce the positive effect of psychotherapy on resilience and confirm that resilience is a dynamic process that can be changed in psychotherapy. Nevertheless, our data should be interpreted considering some limitations. We did not have a control group nor did we assess the resilience of the subjects who dropped out from treatment, which did not allow us to affirm that resilience improved due to psychotherapy. However, our data showed a significant increase in resilience scores from baseline to followup assessments (after psychotherapy). Resilience could possibly be improved because of psychological treatment; however, more studies with a control group are needed to confirm this finding.
According to the literature, less than 50% of patients with major depressive disorder complete six months of follow-up 13 after the end of treatment.
Authors report that patients with high resilience tend to follow treatment correctly and seek for health care. 29 However, in this study, no differences were found between the resilience scores of individuals who completed the treatment and of those who dropped out before completion. In this particular case, resilience
was not a predictor of treatment adherence. To the best of our knowledge, there are no studies assessing resilience as a contributing factor to the permanence of the individual in treatment or dropout rates associated with therapeutic resilience.
A limitation of the present study was its small sample, which may have influenced the interpretation of the results. Our results showed a weak correlation, possibly due to the small sample size. Thus, more studies are needed to confirm our findings. Another limitation was that the findings could not be extrapolated to patients with severe depression or suicide risk, since these characteristics were considered exclusion criteria for this study. In addition, resilience is a new concept in the research field, which may limit the interpretation of the findings. In contrast, this study presents some important contributions. The sample was composed of young people with few previous interventions, probably with early episodes of depression. Similarly, the evaluation of depressive symptoms and resilience at the end of treatment and at six-month follow-up may have contributed to differentiate our study from others using these variables. It is noteworthy that most of the studies tend to focus on risk factors for poor therapeutic response and the few studies that evaluate the effect of resilience generally investigate very specific samples.
The role of resilience-related factors in psychotherapy is still little explored. 30 There is lack of research to assess resilience as a positive predictor of therapeutic response after brief cognitive interventions. Brief interventions and less costly therapies facilitate research in this field, benefiting patients in remission of depressive and anxiety symptoms, and therefore improving their quality of life. However, further studies are needed to advance research on this topic.
